On November 28, 2018, the Company issued 492 shares at a weighted average grant date fair value of $13.49, all of which are restricted stock subject to vesting. The majority of these shares will vest ratably over a four-year period commencing on the first anniversary of the grant date. Non-cash equity-based compensation expense associated with the grant will be approximately $6,156 over the requisite service period.

On June 3, 2019, the Company issued 152 restricted stock units (“RSUs”) at a weighted average grant date fair value of $16.86, all of which are subject to vesting. These RSUs will vest ratably over either a three-year or a four-year period commencing on the first anniversary of the grant date. Non-cash equity-based compensation expense associated with the grant will be approximately $2,379 over the requisite service period.

On November 28, 2018, the Company issued 1,123 stock options at a weighted average exercise price of $13.49 and a weighted average grant date fair value of $5.85, the majority of which will vest and become exercisable ratably over a four-year period commencing on the first anniversary of the grant date. Non-cash equity-based compensation expense associated with the grant will be approximately $6,091 over the requisite service period.

On June 3, 2019, the Company issued 138 stock options at a weighted average exercise price of $16.86 and a weighted average grant date fair value of $6.84, all of which will vest and become exercisable ratably over a four-year period commencing on the first anniversary of the grant date. Non-cash equity-based compensation expense associated with the grant will be approximately $875 over the requisite service period.

Information regarding the total equity-based compensation expense, for the periods indicated is as follows:

Three Months Ended

June 30,

Nine Months Ended

June 30,

2019

2018

2019

2018

Total equity-based compensation expense recognized

307

14,951

11,826

20,753

At June 30, 2019 the aggregate unamortized value of outstanding stock-based compensation awards was approximately $46,961, with a weighted average remaining life of 1.6 years.

The Company’s stockholders approved in 2018 the Company’s 2018 Employee Stock Purchase Plan (the “ESPP”). A total of 1,100 shares of the Company’s common stock were made available for sale on October 22, 2018 and a portion thereof will be issued on November 14, 2019.